Exane Derivatives
- SEC CIK
- 0001623883
- Latest filing
- Jul 12, 2022
AVIR holding history
Atea Pharmaceuticals, Inc. in every 13F filed by Exane Derivatives, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AVIR overviewAll 13F holders of AVIRFull Q2 2022 holdings
- Shares (Q2 2022)
- 78
- Value
- $554
- % of portfolio
- <0.1%
- Quarters held
- 5
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2022 | 78 | $554 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 78 | $563 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 78 | $697 | <0.1% | −4,688−98.4% | Reduced | Holders |
| Q3 2021 | 4,766 | $167.1K | <0.1% | +576+13.7% | Added | Holders |
| Q2 2021 | 4,190 | $93.2K | <0.1% | +4,190 | New | Holders |